FDA signs off on GSK label expansion for Tdap vaccine
The FDA announced last week that it expanded GSK’s Tdap vaccine, Boostrix, for expectant mothers in the third trimester of pregnancy to prevent whooping cough …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
